These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37080433)

  • 21. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity.
    Fayyaz S; Japtok L; Schumacher F; Wigger D; Schulz TJ; Haubold K; Gulbins E; Völler H; Kleuser B
    Cell Physiol Biochem; 2017; 43(2):445-456. PubMed ID: 28922661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysophosphatidic acid and its receptor LPA
    Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
    Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LPA receptor signaling: pharmacology, physiology, and pathophysiology.
    Yung YC; Stoddard NC; Chun J
    J Lipid Res; 2014 Jul; 55(7):1192-214. PubMed ID: 24643338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LPA receptors: subtypes and biological actions.
    Choi JW; Herr DR; Noguchi K; Yung YC; Lee CW; Mutoh T; Lin ME; Teo ST; Park KE; Mosley AN; Chun J
    Annu Rev Pharmacol Toxicol; 2010; 50():157-86. PubMed ID: 20055701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LPA and its analogs-attractive tools for elucidation of LPA biology and drug development.
    Kano K; Arima N; Ohgami M; Aoki J
    Curr Med Chem; 2008; 15(21):2122-31. PubMed ID: 18781939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linking medicinal cannabis to autotaxin-lysophosphatidic acid signaling.
    Eymery MC; McCarthy AA; Hausmann J
    Life Sci Alliance; 2023 Feb; 6(2):. PubMed ID: 36623871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
    Gendaszewska-Darmach E
    Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta.
    Chen SU; Lee H; Chang DY; Chou CH; Chang CY; Chao KH; Lin CW; Yang YS
    Endocrinology; 2008 Nov; 149(11):5888-96. PubMed ID: 18617617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
    Meduri B; Pujar GV; Durai Ananda Kumar T; Akshatha HS; Sethu AK; Singh M; Kanagarla A; Mathew B
    Eur J Med Chem; 2021 Oct; 222():113574. PubMed ID: 34126459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous lysophosphatidic acid (LPA
    Sattikar A; Dowling MR; Rosethorne EM
    Br J Pharmacol; 2017 Feb; 174(3):227-237. PubMed ID: 27864940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
    Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of lysophosphatidic acid and its receptors in the kidney.
    Park F; Miller DD
    Physiol Genomics; 2017 Nov; 49(11):659-666. PubMed ID: 28939644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.
    Geraldo LHM; Spohr TCLS; Amaral RFD; Fonseca ACCD; Garcia C; Mendes FA; Freitas C; dosSantos MF; Lima FRS
    Signal Transduct Target Ther; 2021 Feb; 6(1):45. PubMed ID: 33526777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse effects of LPA receptors on cell motile activities of cancer cells.
    Tsujiuchi T; Hirane M; Dong Y; Fukushima N
    J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition.
    Fukasawa K; Gotoh M; Uwamizu A; Hirokawa T; Ishikawa M; Shimizu Y; Yamamoto S; Iwasa K; Yoshikawa K; Aoki J; Murakami-Murofushi K
    Sci Rep; 2021 Aug; 11(1):17360. PubMed ID: 34462512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical Control of Lysophosphatidic Acid Signaling.
    Morstein J; Dacheux MA; Norman DD; Shemet A; Donthamsetti PC; Citir M; Frank JA; Schultz C; Isacoff EY; Parrill AL; Tigyi GJ; Trauner D
    J Am Chem Soc; 2020 Jun; 142(24):10612-10616. PubMed ID: 32469525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
    Federico L; Pamuklar Z; Smyth SS; Morris AJ
    Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish.
    Yukiura H; Hama K; Nakanaga K; Tanaka M; Asaoka Y; Okudaira S; Arima N; Inoue A; Hashimoto T; Arai H; Kawahara A; Nishina H; Aoki J
    J Biol Chem; 2011 Dec; 286(51):43972-43983. PubMed ID: 21971049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autotaxin and LPA receptor signaling in cancer.
    Houben AJ; Moolenaar WH
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
    Orosa B; García S; Conde C
    Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.